← back to search

Xiaobin Lv

Third Hospital of Nanchang ·
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer-related molecular mechanisms research, RNA modifications and cancer, MicroRNA in disease regulation, and RNA Research and Splicing.
h-index
22
citations
3,232
works
52
NIH funding
primary concept
email

Recent publications

Solute carrier family 35 member A2 regulates mitophagy through the PI3K/AKT/mTOR axis, promoting the proliferation, migration, and invasion of osteosarcoma cells
Gene 2023cited by 8position: middledoi
LncRNA LBX2-AS1 impacts osteosarcoma sensitivity to JQ-1 by sequestering miR-597-3p away from BRD4
Frontiers in Oncology 2023cited by 6position: lastdoi
Role of LncRNAs in regulating cancer amino acid metabolism
Cancer Cell International 2021cited by 34position: middledoi
The novel prognostic risk factor STC2 can regulate the occurrence and progression of osteosarcoma via the glycolytic pathway
Biochemical and Biophysical Research Communications 2021cited by 29position: lastdoi
Author Correction: Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma
Nature Communications 2021cited by 19position: middledoi
HDAC6 inhibitor WT161 performs anti-tumor effect on osteosarcoma and synergistically interacts with 5-FU
Bioscience Reports 2021cited by 18position: lastdoi
Long non‑coding RNA MIR17HG sponges microRNA‑21 to upregulate PTEN and regulate homoharringtonine‑based chemoresistance of acute myeloid leukemia cells
Oncology Letters 2021cited by 18position: lastdoi
Serglycin promotes proliferation, migration, and invasion via the JAK/STAT signaling pathway in osteosarcoma
Aging 2021cited by 8position: lastdoi
Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma
Nature Communications 2020cited by 670position: middledoi
lncRNA CISAL Inhibits BRCA1 Transcription by Forming a Tertiary Structure at Its Promoter
iScience 2020cited by 25position: middledoi
LncRNA GSEC promotes the proliferation, migration and invasion by sponging miR-588/ EIF5A2 axis in osteosarcoma
Biochemical and Biophysical Research Communications 2020cited by 23position: middledoi
<p>Identification of BRMS1L as Metastasis Suppressing Gene in Esophageal Squamous Cell Carcinoma</p>
Cancer Management and Research 2020cited by 20position: lastdoi
Long Noncoding RNA MPRL Promotes Mitochondrial Fission and Cisplatin Chemosensitivity via Disruption of Pre-miRNA Processing
Clinical Cancer Research 2019cited by 73position: middledoi
Exosomes May Be the Potential New Direction of Research in Osteoarthritis Management
BioMed Research International 2019cited by 26position: middledoi
HDAC6 inhibitor WT161 induces apoptosis in retinoblastoma cells and synergistically interacts with cisplatin
Translational Cancer Research 2019cited by 16position: middledoi
LncRNA SNHG5 promotes the progression of osteosarcoma by sponging the miR-212-3p/SGK3 axis
Cancer Cell International 2018cited by 107position: lastdoi
Artesunate suppresses the viability and mobility of prostate cancer cells through UCA1, the sponge of miR-184
Oncotarget 2017cited by 60position: middledoi
LncRNA PANDAR regulates the G1/S transition of breast cancer cells by suppressing p16INK4A expression
Scientific Reports 2016cited by 87position: lastdoi
A Cytoplasmic NF-κB Interacting Long Noncoding RNA Blocks IκB Phosphorylation and Suppresses Breast Cancer Metastasis
Cancer Cell 2015cited by 951position: middledoi
Aspirin Suppresses the Growth and Metastasis of Osteosarcoma through the NF-κB Pathway
Clinical Cancer Research 2015cited by 112position: middledoi
miR-483-5p determines mitochondrial fission and cisplatin sensitivity in tongue squamous cell carcinoma by targeting FIS1
Cancer Letters 2015cited by 86position: middledoi
E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter
Oncotarget 2015cited by 78position: middledoi
Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p–MFF axis
Oncotarget 2015cited by 52position: middledoi
Hypermethylation of TET1 Promoter Is a New Diagnosic Marker for Breast Cancer Metastasis
Asian Pacific Journal of Cancer Prevention 2015cited by 18position: lastdoi
Long Noncoding RNA HOTAIR Is a Prognostic Marker for Esophageal Squamous Cell Carcinoma Progression and Survival
PLoS ONE 2013cited by 149position: firstdoi
The Overexpression of Hypomethylated miR-663 Induces Chemotherapy Resistance in Human Breast Cancer Cells by Targeting Heparin Sulfate Proteoglycan 2 (HSPG2)
Journal of Biological Chemistry 2013cited by 116position: middledoi
Lin28 Induces Epithelial-to-Mesenchymal Transition and Stemness via Downregulation of Let-7a in Breast Cancer Cells
PLoS ONE 2013cited by 86position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xiaofeng Tang · Hefei University of Technology9 papers (2015–2021)Zhiping Zhang · Harbin University of Science and Technology8 papers (2018–2023)Feifei Zhang · Yale Cancer Center7 papers (2018–2023)Renfeng Liu · Nanchang University7 papers (2019–2021)Yiping Liang · Nanchang University6 papers (2020–2021)Cheng Ju · Nanchang University6 papers (2019–2021)Jun Sun · Nanchang University5 papers (2019–2021)Yuhong Guo · Fudan University5 papers (2020–2021)Bin Lv · Fudan University4 papers (2020–2021)Erwei Song · Southern Medical University4 papers (2013–2015)Duo Zeng · Nanchang University4 papers (2021–2023)Herui Yao · Cancer Clinic3 papers (2013–2015)Qiang Liu · Stanford University3 papers (2013–2015)Haiyan Hu · Shanghai Jiao Tong University3 papers (2013–2020)Bodu Liu · Cold Spring Harbor Laboratory3 papers (2015–2015)Ruihao Zhou · Nanchang University3 papers (2018–2020)Lijuan Sun · Qinghai University3 papers (2015–2015)Jiongfeng Zhang · The First Affiliated Hospital, Sun Yat-sen University2 papers (2023–2023)Gaoyang Qu · Nanchang University2 papers (2023–2023)Yi Sang · Central South University2 papers (2015–2016)